Full name
"APTEKA ESKULAP D.NIEWIADOMSKA-ŚLIWIŃSKA I SPÓŁKA" SPÓŁKA JAWNA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | ||||
Gross profit (loss) | 0,4 | 0,5 | 0,5 | -2,8 |
EBITDA | 0 | 0 | 0 | -100 |
Short time liabilities | 0,4 | 0,6 | 0,6 | 14,8 |
Other operating costs | ||||
Equity capital | 0,5 | 0 | 0 | 0 |
Operating profit (EBIT) | 0 | 0 | 0 | 0 |
Assets | 0,9 | 1,1 | 1,1 | 6,5 |
Net profit (loss) | 0,4 | 0,5 | 0,5 | -2,8 |
Cash | 0,3 | 0,4 | 0,2 | -33,6 |
Net income from sale | 5,5 | 6 | 6,3 | 4,6 |
Liabilities and provisions for liabilities | 0,4 | 0,6 | 0,6 | 14,8 |
Working assets | 0,9 | 1,1 | 1,1 | 6,5 |
Other income costs | ||||
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | ||||
Equity capital to total assets | 53,4 | 1 | 0,9 | -0,1 |
Gross profit margin | 8,1 | 8,3 | 7,7 | -0,6 |
EBITDA Margin | 0 | 0 | 0 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | ||||
Current financial liquidity indicator | 2.1442060470581055 | 1.900390386581421 | 1.7626795768737793 | -0,1 |
Net dept to EBITDA |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane